Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Core Binding Factor Leukemias Utilize a Physiologic Sense/Antisense Promoter Switch Employed By T-Cells

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-140776

Published: 2020

Journal Articles

Phase II Study of Azacitidine (Vidaza®, Aza) and Donor Lymphocyte Infusions (DLI) As First Salvage Therapy in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Relapsing After Allogeneic Hematopoietic Stem Cell Transplantation (allo-SCT): Final Results From the AZARELA-Trial (NCT-00795548)

Thomas Schroeder, MD, Akos Czibere, MD, PhD, Nicolaus Kröger, Uwe Platzbecker, MD, Gesine Bug, Lutz Uharek, Prof., Dr., Thomas Luft, Christine Wolschke, Ingmar Bruns, MD, Fabian Zohren, MD, Roland Fenk, Rainer Haas, MD, Prof, Guido Kobbe, MD

Blood (2011) 118 (21): 656.

https://doi.org/10.1182/blood.V118.21.656.656

Published: 2011

Journal Articles

The Disease-Related Bone Marrow Microenvironment Alters Hematopoietic Stem and Progenitor Function in Multiple Myeloma Patients

Ingmar Bruns, MD, Ron-Patrick Cadeddu, Ines Brückmann, Sebastian Buest, Julia Fröbel, Thomas Schroeder, Stefanie Geyh, Ali-Nuri Hünerlitürkoglu, Guido Kobbe, MD, Roland Fenk, Andreas Trumpp, Akos Czibere, MD, PhD, Rainer Haas

Blood (2011) 118 (21): 2898.

https://doi.org/10.1182/blood.V118.21.2898.2898

Published: 2011

Journal Articles

The Neuropeptides Orexin a and B Have An Impact on Functional Properties of Human CD34+ Stem and Progenitor Cells.

Ingmar Bruns, MD, PhD, Patrick Cadeddu, Sebastian Büst, Boris Goerg, Johannes C Fischer, Oliver Selbach, Ulrich Steidl, MD, PhD, Ralf Kronenwett, Rainer Haas, Guido Kobbe, Akos Czibere, MD, PhD

Blood (2008) 112 (11): 1393.

https://doi.org/10.1182/blood.V112.11.1393.1393

Published: 2008

Journal Articles

Ap-1 Family Members C-Jun, JunB and Fra-2 Mediate Apoptosis and Differentiation in AML through Activation of GADD45á and ADFP Following Non-Steroidal Anti-Inflammatory Drug Treatment.

Akos Czibere, MD, PhD, Raminder Singh, PhD, Ingmar Bruns, MD, PhD, Luiz Fernando Zerbini, PhD, Rainer Haas

Blood (2008) 112 (11): 1196.

https://doi.org/10.1182/blood.V112.11.1196.1196

Published: 2008

Journal Articles

Imatinib Induced Molecular Response in CD34+ Hematopoietic Stem and Progenitor Cells of Patients with Chronic Myeloid Leukemia Following the First Week of Therapy

Daniela Bruennert, Akos Czibere, MD, PhD, Ingmar Bruns, MD, PhD, Sabrina Pechtel, Norbert Gattermann, MD, Ralf Kronenwett, Rainer Haas, Neumann Frank

Blood (2008) 112 (11): 3231.

https://doi.org/10.1182/blood.V112.11.3231.3231

Published: 2008

Journal Articles

Hematopoiesis in Chronic Phase CML emerges from Hematopoietic Stem Cells with a Transcriptional Phenotype Resembling Normal Myeloid Progenitor Cells.

Ingmar Bruns, MD, PhD, Akos Czibere, MD, PhD, Patrick Cadeddu, Frederik Roels, Johannes C Fischer, Sebastian Büst, Daniela Brünnert, Ulrich Steidl, MD, PhD, Benedict Brors, Norbert Gattermann, MD, Ralf Kronenwett, Rainer Haas

Blood (2008) 112 (11): 3365.

https://doi.org/10.1182/blood.V112.11.3365.3365

Published: 2008

Journal Articles

Treatment with Natalizumab in Patients with Multiple Sclerosis Is Associated with Increased Numbers of Circulating CD34+ Cells in the Peripheral Blood.

Fabian Zohren, MD, Akos Czibere, MD, Diamandis Toutzaris, MD, Hans-Peter Hartung, MD, Ingmar Bruns, MD, Rainer Haas, MD

Blood (2007) 110 (11): 4916.

https://doi.org/10.1182/blood.V110.11.4916.4916

Published: 2007

Journal Articles

Fludarabine, Amsacrine, High-Dose Cytarabine and Total Body Irridation Followed by Allogeneic Stem Cell Transplantation for the Treatment of High Risk or Relapsed Acute Lymphoblastic Leukemia.

Fabian Zohren, MD, Thorsten Graef, MD, Ingmar Bruns, MD, Akos Czibere, MD, Fenk Roland, MD, Haas Rainer, MD, Kobbe Guido

Blood (2007) 110 (11): 5086.

https://doi.org/10.1182/blood.V110.11.5086.5086

Published: 2007

Journal Articles

Molecular Level of Minimal Residual Disease in Bone Marrow Before High-Dose Therapy and Autologous Stem Cell Transplantation Is a Prognostic Parameter in Patients with Multiple Myeloma.

Roland Fenk, MD, Mark Korthals, Nina Sehnke, Ingmar Bruns, MD, Akos Czibere, MD, Fabian Zohren, Nancy Safaian, Ariane Dienst, Leilani Ruf, MD, Frank Neumann, MD, Rainer Haas, MD, Ralf Kronenwett, MD, Guido Kobbe, MD

Blood (2007) 110 (11): 1496.

https://doi.org/10.1182/blood.V110.11.1496.1496

Published: 2007

Journal Articles

Sequential Induction Chemotherapy, and Early Intensified Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with High-Risk Myeloid Leukemia.

Thorsten Graef, MD, Nikola Schmittner, Frank Neumann, MD, Roland Fenk, MD, Fabian Zohren, MD, Akos Czibere, MD, Norbert Gattermann, MD, Rainer Haas, MD, Guido Kobbe, MD

Blood (2006) 108 (11): 5367.

https://doi.org/10.1182/blood.V108.11.5367.5367

Published: 2006

Journal Articles

5-Azacitidine in Combination with Donor Lymphocyte Infusions for the Treatment of Patients with MDS or AML Relapsing after Allogeneic Stem Cell Transplantation.

Akos Czibere, MD, Thorsten Graef, MD, Jens Lind, Norbert Gattermann, MD, Fabian Zohren, MD, Roland Fenk, MD, Rainer Haas, MD, Guido Kobbe, MD

Blood (2006) 108 (11): 5341.

https://doi.org/10.1182/blood.V108.11.5341.5341

Published: 2006

Journal Articles

A Transcriptional Signature Distinguishing Short and Long-Term Surviving Patients with MDS.

Akos Czibere, MD, Christian Prall, MD, Ulrich Steidl, MD, PhD, Ingmar Bruns, MD, Andrea Kuendgen, MD, Aristoteles Giagounidis, MD, Rainer Haas, MD, Guido Kobbe, MD, Ulrich Germing, MD, Manuel Aivado, MD

Blood (2006) 108 (11): 4866.

https://doi.org/10.1182/blood.V108.11.4866.4866

Published: 2006

Journal Articles

Induction of Complete Remission with 5-Azacytidine in a Patient with Acute Myeloid Leukemia Refractory to Intensive Chemotherapy.

Andrea Kuendgen, MD, Thorsten Graef, MD, Sabine Knipp, MD, Barbara Hildebrandt, MD, Akos Czibere, MD, Ali N. Huenerlituerkoglu, MD, Ulrich Germing, MD, Rainer Haas, MD, Norbert Gattermann, MD, Guido Kobbe, MD

Blood (2005) 106 (11): 4600.

https://doi.org/10.1182/blood.V106.11.4600.4600

Published: 2005

Journal Articles

Exisulind Selectively Induces Apoptosis Via C-Jun Kinase Activation in MDS and sAML/MDS.

Akos Czibere, MD, Wolf C. Prall, MD, Sabine Knipp, MD, Andrea Kuendgen, MD, Luiz F. Zerbini, PhD, Ulrich Germing, MD, Rainer Haas, MD, Towia A. Libermann, PhD, Norbert Gattermann, MD, Manuel Aivado, MD

Blood (2005) 106 (11): 4902.

https://doi.org/10.1182/blood.V106.11.4902.4902

Published: 2005

Journal Articles

Valproic Acid (VPA) Achieves High Response Rates in Patients with Low-Risk Myelodysplastic Syndromes.

Andrea Kuendgen, MD, Mathias Schmid, MD, Sabine Knipp, MD, Akos Czibere, MD, Barbara Hildebrandt, MD, Christian Steidl, MD, Rainer Haas, MD, Ulrich Germing, MD, Hartmut Doehner, MD, Norbert Gattermann, MD

Blood (2005) 106 (11): 789.

https://doi.org/10.1182/blood.V106.11.789.789

Published: 2005

Journal Articles

Age-Related Transcription Levels of KU70 and BIK in CD34+ Hematopoietic Stem and Progenitor Cells.

Wolf C. Prall, MD, Akos Czibere, MD, Franck Grall, PhD, Luiz F. Zerbini, PhD, Markus Jaeger, MD, Dimitrios Spentzos, MD, Towia A. Libermann, PhD, Norbert Gattermann, MD, Manuel Aivado, MD, Rainer Haas, MD

Blood (2005) 106 (11): 4205.

https://doi.org/10.1182/blood.V106.11.4205.4205

Published: 2005

NARROW

Core Binding Factor Leukemias Utilize a Physiologic Sense/Antisense Promoter Switch Employed By T-Cells

The Disease-Related Bone Marrow Microenvironment Alters Hematopoietic Stem and Progenitor Function in Multiple Myeloma Patients

The Neuropeptides Orexin a and B Have An Impact on Functional Properties of Human CD34+ Stem and Progenitor Cells.

Ap-1 Family Members C-Jun, JunB and Fra-2 Mediate Apoptosis and Differentiation in AML through Activation of GADD45á and ADFP Following Non-Steroidal Anti-Inflammatory Drug Treatment.

Imatinib Induced Molecular Response in CD34+ Hematopoietic Stem and Progenitor Cells of Patients with Chronic Myeloid Leukemia Following the First Week of Therapy

Hematopoiesis in Chronic Phase CML emerges from Hematopoietic Stem Cells with a Transcriptional Phenotype Resembling Normal Myeloid Progenitor Cells.

Treatment with Natalizumab in Patients with Multiple Sclerosis Is Associated with Increased Numbers of Circulating CD34+ Cells in the Peripheral Blood.

Fludarabine, Amsacrine, High-Dose Cytarabine and Total Body Irridation Followed by Allogeneic Stem Cell Transplantation for the Treatment of High Risk or Relapsed Acute Lymphoblastic Leukemia.

Molecular Level of Minimal Residual Disease in Bone Marrow Before High-Dose Therapy and Autologous Stem Cell Transplantation Is a Prognostic Parameter in Patients with Multiple Myeloma.

Sequential Induction Chemotherapy, and Early Intensified Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with High-Risk Myeloid Leukemia.

5-Azacitidine in Combination with Donor Lymphocyte Infusions for the Treatment of Patients with MDS or AML Relapsing after Allogeneic Stem Cell Transplantation.

A Transcriptional Signature Distinguishing Short and Long-Term Surviving Patients with MDS.

Induction of Complete Remission with 5-Azacytidine in a Patient with Acute Myeloid Leukemia Refractory to Intensive Chemotherapy.

Exisulind Selectively Induces Apoptosis Via C-Jun Kinase Activation in MDS and sAML/MDS.

Valproic Acid (VPA) Achieves High Response Rates in Patients with Low-Risk Myelodysplastic Syndromes.

Age-Related Transcription Levels of KU70 and BIK in CD34+ Hematopoietic Stem and Progenitor Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only